Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Azithramycine
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kratzer C et al. | Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae. | 2007 | Wien. Klin. Wochenschr. | pmid:17571234 |
Arnez M et al. | Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. | 2002 | Wien. Klin. Wochenschr. | pmid:12422590 |
Maraspin V et al. | Development of erythema migrans in spite of treatment with antibiotics after a tick bite. | 2002 | Wien. Klin. Wochenschr. | pmid:12422612 |
MUW researcher of the month Franz Ratzinger. | 2016 | Wien. Klin. Wochenschr. | pmid:27113348 | |
[Newly approved specialty drugs in Austria and new knowledge about currently available specialty drugs. Zithromax capsules, dried syrup]. | 1994 | Wien. Klin. Wochenschr. | pmid:7975673 | |
Schilling F | [SAPHO syndrome. A contribution to discussion]. | 2003 | Wien. Klin. Wochenschr. | pmid:12674695 |
Subedi Y | Around Manaslu Ultramarathon: Diarrhea Is Still the King. | 2017 | Wilderness Environ Med | pmid:28735656 |
Sawhney N | MAC prophylaxis in the era of polypharmacy. | 1999 May-Jun | WMJ | pmid:10414219 |
Haggerty CL and Ness RB | Diagnosis and treatment of pelvic inflammatory disease. | 2008 | Womens Health (Lond Engl) | pmid:19072503 |
Shan LS et al. | Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children. | 2017 | World J Pediatr | pmid:28130749 |
Dolezelova E et al. | Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats. | 2017 | World J. Gastroenterol. | pmid:29209109 |
Ivashkin VT et al. | Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. | 2002 | World J. Gastroenterol. | pmid:12378634 |
Dong J et al. | Azithromycin-containing versus standard triple therapy for Helicobacter pylori eradication: a meta-analysis. | 2009 | World J. Gastroenterol. | pmid:20027685 |
Babic Z et al. | Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection. | 2005 | World J. Gastroenterol. | pmid:15884110 |
Mousavi S et al. | Azithromycin in one week quadruple therapy for H pylori eradication in Iran. | 2006 | World J. Gastroenterol. | pmid:16874871 |
Salimi A et al. | Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. | 2016 | Xenobiotica | pmid:26068526 |
Haruki Y et al. | [Investigation of Intravenous Azithromycin Treatment Safety When Reducing Solvent for Intensive Care Unit Patients]. | 2015 | Yakugaku Zasshi | pmid:26234357 |
Salgado HR and Roncari AF | Microbiological assay for the determination of azithromycin in ophthalmic solutions. | 2005 | Yao Xue Xue Bao | pmid:16144322 |
Wang JS et al. | [Preparation of lung targeting azithromycin liposomes and its tissue distribution in mice]. | 2005 | Yao Xue Xue Bao | pmid:15952603 |
Schilling F and Wagner AD | [Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report]. | 2000 | Z Rheumatol | pmid:11142932 |